Summary:
To confirm the therapeutic equivalence of FP pMDI 110 mcg and the Reference Standard, Flovent HFA 110 mcg, after a 4 week treatment period in adult subjects with chronic but stable asthma as defined in National Asthma Education and Prevention Program Expert Panel Report 3.
Qualified Participants Must:
• Be diagnosed 12+ months prior
•
Stable meds 4 weeks prior
•
Non-smoker
Qualified Participants May Receive:
Flovent, Fluticasone or placebo, all study related medical exams, compensenation for time and travel.